MAIA Biotechnology, Inc.
MAIA
$1.26
-$0.10-7.35%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 9.72M | 9.32M | 7.84M | 7.55M | 6.95M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 24.27M | 24.96M | 19.78M | 18.43M | 16.96M |
| Operating Income | -24.27M | -24.96M | -19.78M | -18.43M | -16.96M |
| Income Before Tax | -22.40M | -22.34M | -16.17M | -19.70M | -23.25M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -22.40 | -22.34 | -16.17 | -19.70 | -23.25 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -22.40M | -22.34M | -16.17M | -19.70M | -23.25M |
| EBIT | -24.27M | -24.96M | -19.78M | -18.43M | -16.96M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.71 | -0.75 | -0.60 | -0.82 | -1.12 |
| Normalized Basic EPS | -0.44 | -0.47 | -0.37 | -0.51 | -0.70 |
| EPS Diluted | -0.71 | -0.75 | -0.60 | -0.82 | -1.12 |
| Normalized Diluted EPS | -0.44 | -0.47 | -0.37 | -0.51 | -0.70 |
| Average Basic Shares Outstanding | 128.39M | 116.24M | 106.93M | 98.84M | 88.74M |
| Average Diluted Shares Outstanding | 128.39M | 116.24M | 106.93M | 98.84M | 88.74M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |